Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | F7 | P08709 | 2/20 | 0.52 |
| ▸ | F3 | P13726 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23566850 | 1.00 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL93117 | 1.00 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL9133779 | 1.00 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL17262056 | 1.00 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL9133782 | 1.00 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1F7 | |
| Iodide SCHEMBL8717413 | 0.96 | FAAH (0.52) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL25214228 | 0.96 | FAAH (0.52) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL28033081 | 0.96 | FAAH (0.60) | FAAHTRPV1TSHRALDH1A1F7 | |
| SCHEMBL2851962 | 0.93 | FAAH (0.65) | FAAHTRPV1F7F3LMNA | |
| Decane SCHEMBL11847893 | 0.93 | FAAH (0.65) | FAAHTRPV1TSHRF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106622376-B | A kind of isomerization of internal olefin and hydroformylation reaction method and catalyst | 武汉凯特立斯科技有限公司 | 2019-10-11 | — | — | CN | claimed |
| CN-106824282-B | A kind of hydroformylation reaction method and catalyst using rhodium ruthenium bimetallic and four tooth Phosphine ligands | 武汉凯特立斯科技有限公司 | 2019-10-11 | — | — | CN | claimed |
| EP-1395534-B1 | IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS | MATERIA INC (US) | 2017-08-30 | — | — | EP | claimed |
| CN-106824282-A | The hydroformylation reaction method and catalyst of a kind of use rhodium ruthenium bimetallic and four tooth Phosphine ligands | 武汉凯特立斯科技有限公司 | 2017-06-13 | — | — | CN | claimed |
| CN-106622376-A | Internal olefin isomerization and hydroformylation reaction method, and catalyst | 武汉凯特立斯科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| US-7442489-B2 | Photoresist composition and method of forming a photoresist pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-10-28 | — | — | US | claimed |
| EP-1413610-B1 | Nonionic additives to control puddling in inkjet inks | HEWLETT PACKARD DEVELOPMENT CO (US) | 2007-05-16 | — | — | EP | claimed |
| US-20060160021-A1 | Photoresist composition and method of forming a photoresist pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-07-20 | — | — | US | claimed |
| US-6852153-B2 | Nonionic additives to control puddling in inkjet inks | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2005-02-08 | — | — | US | claimed |
| EP-0871593-B1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | MYCELX TECHNOLOGIES CORP (US) | 2004-11-10 | — | — | EP | claimed |
| EP-1413610-A1 | Nonionic additives to control puddling in inkjet inks | Hewlett-Packard Development Company, L.P. (US) | 2004-04-28 | — | — | EP | claimed |
| US-20040055506-A1 | Nonionic additives to control puddling in inkjet inks | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2004-03-25 | — | — | US | claimed |
| US-5837146-A | HOMOGENOUS THERMAL REACTION PRODUCT OF AN ALKYL(METH)ACRYLATE (CO)POLYMER MODIFIED WITH UNSATURATED OIL COMPONENT SUCH AS GLYCERIDE, FATTY ACID, ALKENE, AND/OR ALKYNE; FOR CLEANING ENVIRONMENTAL OIL SPILLS ON WATER | MANSFIELD & ALPER, INC. (US) | 1998-11-17 | — | — | US | claimed |
| EP-0871593-A1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | Mansfield & Alper, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| US-5726856-A | Hexasubstituted guanidinium salts and ultracapacitors employing them as electrolytes | GENERAL ELECTRIC COMPANY (US) | 1998-03-10 | — | — | US | claimed |
| WO-1997022558-A1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | MANSFIELD & ALPER, INC. (US) | 1997-06-26 | — | — | WO | claimed |
| CN-122055206-A | Iron complex catalyst encapsulated in resin, addition-curable composition containing same, and method for producing iron complex catalyst encapsulated in resin | 富士高分子工业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-12617762-B2 | Carboxy derivatives with antiinflamatory properties | SITRYX THERAPEUTICS LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| US-4423276-A | ALPHA OLEFINS FROM INTERNAL OLEFINS USING CYCLOPENTADIENYL-TANTALUM COMPOUNDS AS COMPLEXING AGENTS OR CATALYSTS | SHELL OIL COMPANY (US) | 1983-12-27 | — | — | US | disclosed |
| US-4198352-A | PLATINUM CHLORO-CARBONYL-LIGAND COMPLEX WITH A TIN, ZINC OR GERMANIUM CHLORIDE MODIFIER AS CATALYST | SHELL OIL COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617762-B2 | Carboxy derivatives with antiinflamatory properties | CCR1, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | FAAH 770/4885TRPV1 2562/4885TSHR 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.